Znomics appoints Dr Mark Philip president and CEO
This article was originally published in Scrip
Znomics (US) has named Dr Mark Philip president and chief executive officer. He succeeds Richard Sessions, Znomics' co-founder and interim CEO, who will remain as a consultant to the company and as a member of the board of directors. Dr Philip most recently served as president of Stryker Biotech. Znomics' drug discovery platform is based on its catalogued ZeneMark library of mutations in the zebrafish.